Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-12

Clinical Trial Update: The Effect of Lixisenatide on the Effect of Pituitary Hormones [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of lixisenatide on pituitary hormone levels in healthy individuals and people with type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lixisenatide (lixisenatide)

Snippet

Sponsor: University of Tartu | Conditions: Healthy, Type 1 Diabetes | Phase 4 | Status: UNKNOWN